Cargando…
Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
OBJECTIVE: This study aims to investigate the prevalence of short-term and long-term adverse events associated with tumor necrosis factor-α (TNF-α) blocker treatment in Chinese Han patients suffering from ankylosing spondylitis (AS). METHODS: The study included 402 Chinese Han AS patients treated wi...
Autores principales: | Tong, Qiang, Cai, Qing, de Mooij, Tristan, Xu, Xia, Dai, Shengming, Qu, Wenchun, Zhao, Dongbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357466/ https://www.ncbi.nlm.nih.gov/pubmed/25764452 http://dx.doi.org/10.1371/journal.pone.0119897 |
Ejemplares similares
-
Correction: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
por: Tong, Qiang, et al.
Publicado: (2015) -
Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials
por: Feng, Haihuan, et al.
Publicado: (2023) -
Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010) -
Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
por: Jeong, Hyemin, et al.
Publicado: (2018) -
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis
por: Dai, Qinghong, et al.
Publicado: (2022)